Day/Time: June 14th [US/CAN] @ 1pm ET / 10am PT | [EU] @ 7pm CET / 6pm GMT | [AU] @ 3am AEDT (June 15th)
Presenter: Heather Wilson-Robles, DVM. DACVIM (Oncology)
This program has been submitted (but not yet) approved for 1 hour of continuing education credit in jurisdictions which recognize RACE approval. NOTE: If the program is approved for CE credit, you must watch the webinar LIVE to earn the CE credit.
You will receive additional communications with details about your webinar event as the event date approaches. In the meantime please enjoy other recorded webinars and articles on Heska’s LEARN page.
Thank you!
About our Presenter: Heather Wilson-Robles, DVM. DACVIM (Oncology)
Dr. Heather Wilson-Robles received her DVM from the University of Tennessee in 2003. She completed an internship in Small Animal Medicine and Surgery at the University of Minnesota in 2004 and a residency in Medical Oncology at the University of Wisconsin-Madison in 2007. Dr. Robles joined the Veterinary Small Animal Clinical Sciences Department at Texas A&M University in 2007 as a Clinical Assistant Professor, converted to a tenure track position in 2008 and was awarded tenure in 2014. She held the rank of Professor and served as the assistant department head of research before leaving Texas A&M in 2022 to join United Veterinary Group/Ethos Discovery. Dr. Robles’ research has several main foci- bench based discovery targeting tumor initiating cells while exploiting common druggable pathways between canine and human cancers, diagnostic development in nucleosomics and clinical research using dogs as a model for human pediatric cancer. She has received over $8.1 million in external funding from a variety of sources. She has written over 45 peer reviewed publications, 21 book chapters and authored 40 scientific oral abstracts at national meetings. Dr. Robles is also the Chief Medical Officer for Volition Veterinary Diagnostic Development. She was awarded the TVMA Medical specialist of the year award in 2019 and is a past President of the Veterinary Cancer Society.